Correction
Accepted on 22 Oct 2025
Correction: Leveraging real-world data for safety signal detection and risk management in pre-and post-market settings
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1729828
91 Publications
Volume 5 - 2025
Review
Accepted on 21 Oct 2025
The use of Observed-to-Expected analyses as a signal detection tool in COVID-19 vaccine safety surveillance: lessons learned from an industry perspective
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1650992
- 173 views
Perspective
Published on 17 Oct 2025
Leveraging real-world data for safety signal detection and risk management in pre- and post-market settings
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1626822
- 985 views
Perspective
Published on 16 Oct 2025
Communicating medication risks in pregnancy: Towards shared decision making
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1712216
- 368 views
Policy and Practice Reviews
Accepted on 07 Oct 2025
Post-Approval Safety Studies of Vaccines in Pregnancy: Available Regulatory Guidance and Next Steps Towards the More Efficient Generation of Safety Evidence
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1648854
- 266 views
Perspective
Accepted on 03 Oct 2025
The Role of MedDRA in Global Pharmacovigilance and Public Health during COVID-19: Pandemic Preparedness and Response
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1607642
- 161 views
Opinion
Published on 16 Sep 2025
Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1678074
- 2,077 views
Original Research
Published on 10 Sep 2025
Identifying regulatory outcomes of Non-interventional Post-Authorisation Safety Studies (PASS) in the European repository of studies using publicly available information
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1574430
- 1,493 views
Mini Review
Accepted on 25 Aug 2025
Tokenization Techniques for Privacy-Preserving Healthcare Data: Tokenization Nuts and Bolts
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1599217
- 591 views
Perspective
Published on 15 Aug 2025
A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemic
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1644680
- 2,903 views
Clinical Trial
Published on 11 Aug 2025
Medication beliefs and adherence during and after pregnancy among women at risk for gestational hypertensive disorders
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1610273
- 1,327 views
Editorial
Published on 28 Jul 2025
Editorial: Safety of corticosteroids in respiratory medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1656299
- 1,386 views
Review
Published on 20 Jun 2025
Centralized daily drug management in clinical trial institutions and specific implementation plans
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1620314
- 1,460 views
Methods
Published on 26 May 2025
Federated learning: a privacy-preserving approach to data-centric regulatory cooperation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579922
- 2,702 views
Review
Published on 24 Apr 2025
Corticosteroids in lung cancer
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1528468
- 3,726 views
Original Research
Published on 13 Mar 2025
Developing decision support algorithm for hypertension medications for use in a digital therapeutic system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
- 1,740 views